Patents by Inventor RYOGEN LLC

RYOGEN LLC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130189691
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 and methods of use.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130189695
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26) and methods of use.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130189694
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 and methods of use.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130189693
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human SMS3 (SMS3) and methods of use.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130189697
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human and tumor suppressing subtransferable candidate 4 (TSSC4) and methods of use.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130137756
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: November 19, 2012
    Publication date: May 30, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130130251
    Abstract: Provided are isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: November 19, 2012
    Publication date: May 23, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130130250
    Abstract: Provided are isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: November 19, 2012
    Publication date: May 23, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130130252
    Abstract: Provided are isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: November 19, 2012
    Publication date: May 23, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC
  • Publication number: 20130071845
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: November 19, 2012
    Publication date: March 21, 2013
    Applicant: RYOGEN LLC
    Inventor: RYOGEN LLC